Purchase of Placebo and Lansoprazole for TIPAL Project

The procurement process was conducted by the University of East Anglia, a sub-central government public authority located at Norwich Research Park, Norwich, United Kingdom. The contract, awarded on 18th November 2025, pertains to the industry of pharmaceutical goods, specifically the procurement of Placebo and Lansoprazole for the TIPAL Project. The procurement was facilitated through a direct method, categorised as "Below threshold - without competition."

This contract has reached the award stage with Eramol (UK) Ltd as the supplier. The contract commenced on 19th November 2025 and is set to conclude on 31st May 2027, with a total value of £141,855.6. This tender provides significant business growth opportunities, especially for small and medium-sized enterprises (SMEs) in the pharmaceutical and healthcare industries.

Companies that manufacture pharmaceutical products or provide services related to medical laboratories and pharmacy services are particularly well-suited to compete in similar processes. By participating in such procurement activities, businesses can establish valuable partnerships and gain exposure to public sector projects, thus expanding their market presence and credibility within the UK healthcare sector.